43674-004-02 : NDC 2026 Code

43674-004-02 : Naloxone Hydrochloride ( Rezenopy )

Additionally :

You can get information about “43674-004-02” NDC code in 43674-004-02 in HTML format

HTML | 43674-004-02 in TXT (Plain Text) format

TXT | 43674-004-02 in PDF (Portable Document Format)

PDF | 43674-004-02 in XML format

XML formats.

NDC Code : 43674-004-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "43674-004-02",
    "PackageDescription": "2 BLISTER PACK in 1 CARTON (43674-004-02)  / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / .11 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "43674-0004-02",
    "ProductNDC": "43674-004",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Rezenopy",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Naloxone Hydrochloride",
    "DosageFormName": "SPRAY",
    "RouteName": "NASAL",
    "StartMarketingDate": "20250210",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA215487",
    "LabelerName": "Summit Biosciences Inc",
    "SubstanceName": "NALOXONE HYDROCHLORIDE",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/.11mL",
    "Pharm_Classes": "Opioid Antagonist [EPC], Opioid Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2026-01-01",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20251231",
    "StartMarketingDatePackage": "20250210",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}